Fedratinib and Telithromycin: Interaction Details
- Fedratinib
- Inrebic
- Telithromycin
- Ketek
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fedratinib and Telithromycin interaction:
Telithromycin
- Ketek
We don't have a drug information page for Telithromycin yet. Have a question about Telithromycin? Ask a pharmacist, free →
What Happens When You Take Fedratinib With Telithromycin
What can happen when they are taken together (rated Major)
Increased fedratinib and/or exposure and an increased frequency or severity of adverse reactions
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
CYP3A4 is responsible for the of fedratinib, and fedratinib in turn inhibits this enzyme. When a strong CYP3A4 is given together with fedratinib, fedratinib exposure rises, which may heighten the risk of adverse effects.
Giving fedratinib with a CYP3A4 substrate likewise raises exposure to that substrate and the risk of adverse effects from it. In one clinical study, ketoconazole 200 mg twice daily (a strong inhibitor) given with a single 300 mg dose of fedratinib raised fedratinib 3-fold, and in a separate study, a single 2 mg dose of midazolam (a CYP3A4 substrate) given with fedratinib raised midazolam AUC 4-fold.
For patients on fedratinib, alternative therapies that do not strongly inhibit CYP3A4 should be considered. Where fedratinib must be combined with a drug that is a CYP3A4 substrate and also a strong CYP3A4 inhibitor, the fedratinib dose should be lowered to 200 mg orally once daily, patients should be monitored for adverse reactions, and the dose of the other drug should be adjusted. Once the strong CYP3A4 inhibitor is stopped, fedratinib should be raised to 300 mg once daily for 2 weeks, then to 400 mg once daily afterward, as tolerated.1
The Fedratinib and Telithromycin Interaction, Explained
Telithromycin can raise the amount of fedratinib in your body. Both drugs use the same liver enzyme (). Telithromycin is a strong blocker of that enzyme, so fedratinib clears more slowly and builds up. Fedratinib can also slow the of other medicines that use this enzyme, including telithromycin. This can mean more side effects, such as nausea, vomiting, diarrhea, and anemia.
Please don't change or stop either medicine on your own. Tell your pharmacist or doctor you take both. Your care team can often manage this by choosing a different antibiotic, or by adjusting doses and watching you more closely.
Mechanism: Fedratinib is a and a CYP3A4 . Telithromycin is a strong CYP3A4 inhibitor and substrate, so the effect runs in both directions (increased fedratinib exposure and increased telithromycin exposure). Neither drug is a requiring CYP3A4 activation.
- Magnitude: Ketoconazole increased fedratinib about 3-fold. Fedratinib increased midazolam AUC about 4-fold.
- Onset: unspecified. Evidence: probable.
- Management: Prefer an alternative anti-infective that does not strongly inhibit CYP3A4. If is required, reduce fedratinib to 200 mg once daily, monitor for adverse reactions ( toxicity, ), and adjust the telithromycin dose as needed. After the strong inhibitor is stopped, increase fedratinib to 300 mg daily for 2 weeks, then 400 mg daily as tolerated.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fedratinib and Telithromycin Interact
The likely mechanism
of -mediated of fedratinib; inhibition of CYP3A4-mediated metabolism by fedratinib
How to Manage the Fedratinib and Telithromycin Interaction
What your care team may do:
- Consider an alternative antibiotic that does not strongly block .
- If both medicines are truly needed, lower your fedratinib dose (the documented adjustment is 200 mg once daily) and monitor you more closely for side effects. The dose of the other drug may also be adjusted.
- After telithromycin is stopped, step your fedratinib dose back up in stages, as tolerated.
What you should do: Keep taking your medicines as prescribed unless told otherwise. Make sure every prescriber and your pharmacist know you take fedratinib. Report new or worsening nausea, vomiting, diarrhea, or unusual tiredness promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fedratinib or Telithromycin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
2 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: INREBIC oral capsules, fedratinib oral capsules
In a clinical study, giving ketoconazole 200 mg twice daily (a strong ) together with a single 300 mg dose of fedratinib raised fedratinib (0 to infinity) 3-fold. modeling predicts that fedratinib 400 mg once daily given with a strong inhibitor (ketoconazole 400 mg once daily) would double steady-state fedratinib AUC, and the same applies to with a moderate CYP3A4 inhibitor (eg, erythromycin 500 mg three times daily.1
-
Report 2 · Study title
Prescribing information: INREBIC oral capsules, fedratinib oral capsules
When a single 2 mg dose of midazolam (a ) was given with fedratinib, midazolam rose 4-fold.1
Fedratinib and Telithromycin: Common Questions
How serious is the Fedratinib and Telithromycin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fedratinib and Telithromycin interaction managed?
What your care team may do: Consider an alternative antibiotic that does not strongly block . If both medicines are truly needed, lower your fedratinib dose (the documented adjustment is 200 mg once daily) and monitor you more closely for side effects. The dose of the other drug may also be adjusted. After telithromycin is stopped, step your fedratinib dose back up in stages, as tolerated. W… Management is individual — always follow your own care team's guidance.
Is there an alternative to taking Fedratinib with Telithromycin?
What your care team may do: Consider an alternative antibiotic that does not strongly block .
Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Fedratinib and Telithromycin Interaction
Ask in your own words about taking Fedratinib and Telithromycin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: INREBIC(R) oral capsules, fedratinib oral capsules. Bristol-Myers Squibb Company (per FDA), Princeton, NJ, 2023. DailyMed
Other Serious Interactions of Fedratinib and Telithromycin
Also serious with Fedratinib
Also serious with Telithromycin
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Telithromycin
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Sida CordifoliaMajor
- + 175 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.